SARS_CoV_2 Infection Clinical Trials in Omaha
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
- SARS-CoV-2 Infection
- Intramuscular injection
- Intramuscular vaccine
- Birmingham, Alabama
- +90 more
2022-04-04
Apr 4, 2022B
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +4 more
- Athens, Alabama
- +152 more
2022-03-29
Mar 29, 2022B
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b1
- +3 more
- Athens, Alabama
- +165 more
2022-03-25
Mar 25, 2022P
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2 - 2021
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
- Anaheim, California
- +28 more
2022-03-23
Mar 23, 2022V
B
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- Anaheim, California
- +20 more
2022-02-17
Feb 17, 2022N
Not yet recruiting
- SARS-CoV-2 Infection
- Birmingham, Alabama
- +71 more
2022-02-03
Feb 3, 2022O
Completed
- Covid19
- +2 more
- Rayaldee 30Mcg Extended-Release (ER) Capsule
- Placebo
- San Francisco, California
- +9 more
2021-10-14
Oct 14, 2021N
Recruiting
- SARS-CoV-2 Infection
- Moderna COVID-19 Vaccine
- Birmingham, Alabama
- +54 more
2021-08-06
Aug 6, 2021